» Articles » PMID: 34009480

Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa

Abstract

The monthly dapivirine vaginal ring has proven efficacious in reducing HIV incidence in two Phase 3 clinical trials. When considering the potential future availability of the ring to the public, key questions remain about the feasibility of integrating the ring as an HIV prevention intervention into women's lives. We conducted qualitative mapping interviews (n = 66) among women enrolled in MTN-025/HOPE, an open-label trial conducted in Malawi, South Africa, Uganda and Zimbabwe, to examine how home environments influenced use of the dapivirine vaginal ring. Most women had secure places to store their rings including wardrobes, suitcases, and bags. The primary concerns for ring storage were potential tampering from children or rodents. Household overcrowding limited the privacy some women had which made removal and insertion of vaginal rings challenging. Despite these challenges, ring storage, insertion, and removal was feasible across social and living contexts.

Citing Articles

Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial.

Ngure K, Browne E, Reddy K, Friedland B, van der Straten A, Palanee-Phillips T AIDS Behav. 2024; 28(9):2990-3000.

PMID: 38852114 PMC: 11572767. DOI: 10.1007/s10461-024-04382-3.


Editorial: Multipurpose prevention technologies for HIV, STIs and pregnancies.

Friedland B, Thurman A, Nuwagaba-Biribonwoha H, Malcolm R Front Reprod Health. 2024; 6:1384153.

PMID: 38476596 PMC: 10927752. DOI: 10.3389/frph.2024.1384153.


''Ask the way from those who have walked it before"-Grandmothers' roles in health-related decision making and HIV pre-exposure prophylaxis use among pregnant and breastfeeding women in sub-Saharan Africa.

Reddy K, Kemigisha D, Chitukuta M, Dadabhai S, Mathebula F, Tenza S PLoS One. 2022; 17(9):e0271684.

PMID: 36048767 PMC: 9436035. DOI: 10.1371/journal.pone.0271684.

References
1.
Golub S . PrEP Stigma: Implicit and Explicit Drivers of Disparity. Curr HIV/AIDS Rep. 2018; 15(2):190-197. PMC: 5884731. DOI: 10.1007/s11904-018-0385-0. View

2.
Gichane M, Moracco K, Pettifor A, Zimmer C, Maman S, Phanga T . Socioeconomic Predictors of Transactional Sex in a Cohort of Adolescent Girls and Young Women in Malawi: A Longitudinal Analysis. AIDS Behav. 2020; 24(12):3376-3384. DOI: 10.1007/s10461-020-02910-5. View

3.
Montgomery E, Stadler J, Naidoo S, Katz A, Laborde N, Garcia M . Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results. AIDS. 2018; 32(11):1517-1525. PMC: 6230508. DOI: 10.1097/QAD.0000000000001868. View

4.
Griffin J, Ridgeway K, Montgomery E, Torjesen K, Clark R, Peterson J . Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis. PLoS One. 2019; 14(11):e0224898. PMC: 6839883. DOI: 10.1371/journal.pone.0224898. View

5.
Nel A, van Niekerk N, Kapiga S, Bekker L, Gama C, Gill K . Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women. N Engl J Med. 2016; 375(22):2133-2143. DOI: 10.1056/NEJMoa1602046. View